RATIONALE: Diazepam, a benzodiazepine with a relatively rapid onset of clinical effects, has been associated with suicide and other self-aggressive acts. The evidence for this association, however, comes exclusively from retrospective non-experimental studies. Although suggestive, the results of these studies do not support a cause-and-effect relationship between benzodiazepine consumption and self-aggressive behavior. OBJECTIVE: To experimentally examine the effect of diazepam on human self-aggressive behavior under controlled laboratory conditions. METHOD:Forty-six healthy men and women were randomly assigned to receive placebo, or 5 mg or 10 mg diazepam in a double-blind, between-groups design. Participants were then provided the opportunity to self-administer electric shocks during a competitive reaction-time task (the self-aggression paradigm, SAP). Self-aggression was defined by the intensity of shock chosen. RESULTS:Diazepam (10 mg) was associated with higher average shock self-administered than placebo. Subjects receiving 10 mg diazepam were also more likely to attempt to self-administer a shock that they were led to believe was "severe" and painful. Sedation effects were found, but diazepam consumption did not impair memory, attention, concentration, pain threshold, or reaction-time performance. CONCLUSIONS: Clinically relevant diazepam doses may be associated with self-aggressive behaviors at levels that do not significantly impair basic cognitive processes or psychomotor performance.
RCT Entities:
RATIONALE: Diazepam, a benzodiazepine with a relatively rapid onset of clinical effects, has been associated with suicide and other self-aggressive acts. The evidence for this association, however, comes exclusively from retrospective non-experimental studies. Although suggestive, the results of these studies do not support a cause-and-effect relationship between benzodiazepine consumption and self-aggressive behavior. OBJECTIVE: To experimentally examine the effect of diazepam on human self-aggressive behavior under controlled laboratory conditions. METHOD: Forty-six healthy men and women were randomly assigned to receive placebo, or 5 mg or 10 mg diazepam in a double-blind, between-groups design. Participants were then provided the opportunity to self-administer electric shocks during a competitive reaction-time task (the self-aggression paradigm, SAP). Self-aggression was defined by the intensity of shock chosen. RESULTS:Diazepam (10 mg) was associated with higher average shock self-administered than placebo. Subjects receiving 10 mg diazepam were also more likely to attempt to self-administer a shock that they were led to believe was "severe" and painful. Sedation effects were found, but diazepam consumption did not impair memory, attention, concentration, pain threshold, or reaction-time performance. CONCLUSIONS: Clinically relevant diazepam doses may be associated with self-aggressive behaviors at levels that do not significantly impair basic cognitive processes or psychomotor performance.
Authors: Emily L Newman; Kiersten S Smith; Aki Takahashi; Adam Chu; Lara S Hwa; Yang Chen; Joseph F DeBold; Uwe Rudolph; Klaus A Miczek Journal: Psychopharmacology (Berl) Date: 2015-09-17 Impact factor: 4.530
Authors: Mitchell E Berman; Jennifer R Fanning; Casey R Guillot; Angelika Marsic; Joshua Bullock; Michael R Nadorff; Michael S McCloskey Journal: J Consult Clin Psychol Date: 2017-06-05
Authors: Michael S McCloskey; Dror Ben-Zeev; Royce Lee; Mitchell E Berman; Emil F Coccaro Journal: Psychopharmacology (Berl) Date: 2008-10-23 Impact factor: 4.530
Authors: Lucas M Donovan; Carol A Malte; Laura J Spece; Matthew F Griffith; Laura C Feemster; Ruth A Engelberg; David H Au; Eric J Hawkins Journal: Ann Am Thorac Soc Date: 2019-01